Abstract:Apoptosis is a multi-step mechanism of cell self-destruction for maintaining cellular homeostatic balance. Accumulating evidence indicates that abnormal apoptosis promotes the evolution and progression of myelodysplastic syndromes (MDS). As a novel cancer-testis antigen, sperm-associated antigen 6 (SPAG6) has been reported to regulate apoptosis through the tumor necrosis factor-related apoptosis-inducing ligand signaling pathway in the MDS cell line SKM-1. However, the mechanism of the intrinsic cell death pathway for apoptosis induction by SPAG6 silencing is unclear. In the present study, the in vitro effects of SPAG6 silencing were investigated in SKM-1 cells through extensive biochemical and molecular approaches. Western blotting and reverse transcription-quantitative polymerase chain reaction were used to detect the expression of SPAG6 and activation of PTEN/PI3K/AKT signal pathway. Additionally, SKM-1 cells transduced with SPAG6 short hairpin RNA (shRNA) lentivirus were treated with the phosphatidylionositol 3-kinase (PI3K) inhibitor LY294002 or pan caspase inhibitor z-VAD-fmk and the apoptosis rates were measured by flow cytometry, and the expressions of associated proteins were examined by western blot analysis. A mouse xenograft model was also used to further evaluate the effects of SPAG6 knockdown on inducing tumor apoptosis in vivo. Lentivirus-mediated knockdown of SPAG6 in SKM-1 cells increased phosphatase and tensin homolog (PTEN) expression and reduced protein kinase B (AKT) phosphorylation, which in turn resulted in cell apoptosis as evidenced by induced myeloid leukaemia cell differentiation protein Mcl-1 downregulation, cytochrome c release and increased caspase-9 expression. Consistently, the PI3K inhibitor LY294002 synergistically enhanced apoptosis of SKM-1 cells when co-administered with SPAG6 shRNA lentivirus. Furthermore, treatment with the pan caspase inhibitor z-VAD-fmk failed to prevent PTEN activation upon SPAG6 knockdown, suggesting that SPAG6-regulated PTEN expression was caspase activation-independent. In addition, SPAG6 knockdown was associated with DNMT1 downregulation, implying that SPAG6 may indirectly control PTEN expression via DNA methylation. Furthermore, tumor tissues from nonobese diabetic/severe combined immunodeficient mice inoculated with SPAG6-shRNA lentivirus pre-infected SKM-1 cells exhibited significantly elevated apoptosis in the extrinsic and intrinsic pathways. These results demonstrate that SPAG6 silencing induces PTEN expression to regulate apoptosis though the PI3K/AKT pathway, indicating that SPAG6 may be a potential therapeutic target for MDS.

Upregulation of SPAG6 in Myelodysplastic Syndrome: Knockdown Inhibits Cell Proliferation Via AKT/FOXO Signaling Pathway.

Spag6 Silencing Inhibits The Growth Of The Malignant Myeloid Cell Lines Skm-1 And K562 Via Activating P53 And Caspase Activation-Dependent Apoptosis

Spag6 Silencing Induces Apoptosis In The Myelodysplastic Syndrome Cell Line Skm-1 Via The Pten/Pi3k/Akt Signaling Pathway In Vitro And In Vivo

SPAG6 Regulates Cell Apoptosis Through the TRAIL Signal Pathway in Myelodysplastic Syndromes.

Upregulated SPAG6 promotes acute myeloid leukemia progression through MYO1D that regulates the EGFR family expression

Upregulated SPAG6 correlates with increased STAT1 and is associated with reduced sensitivity of interferon‐α response in BCR::ABL1 negative myeloproliferative neoplasms

Methylation Analysis of the Wnt Antagonist in Myelodysplastic Syndrome

A comprehensive pan-cancer analysis revealing SPAG6 as a novel diagnostic, prognostic and immunological biomarker in tumor

SPAG5 As a Novel Biomarker and Potential Therapeutic Target Via Regulating AKT Pathway in Multiple Myeloma.

SPAG9 is Overexpressed in Osteosarcoma, and Regulates Cell Proliferation and Invasion Through Regulation of JunD.

The Emerging Role of Sperm-Associated Antigen 6 Gene in the Microtubule Function of Cells and Cancer

Sparc Silencing Inhibits The Growth Of Acute Myeloid Leukemia Transformed From Myelodysplastic Syndrome Via Induction Of Cell Cycle Arrest And Apoptosis

Annexin A6 is down-regulated through promoter methylation in gastric cancer.

SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis

The CSN5/HSF/SPI1/PU.1 Axis Regulates Cell Proliferation in Hypocellular Myelodysplastic Syndrome Patients

SPAG 9 Controls the Cell Motility , Invasion and Angiogenesis of Human Osteosarcoma Cells

SPAG5 Upregulation Predicts Poor Prognosis in Cervical Cancer Patients and Alters Sensitivity to Taxol Treatment Via the Mtor Signaling Pathway

SPAG9 Promotes Endometrial Carcinoma Cell Invasion Through Regulation of Genes Related to the Epithelial-Mesenchymal Transition.

Human Sperm-Associated Antigen 4 As a Potential Biomarker of Glioblastoma Progression and Prognosis.

SMG1 Acts As a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia.

[Biological role of SPAG5 in the malignant proliferation of gastric cancer cells]